skip to Main Content

InflaRx announces appointment of Tony Gibney to its Board of Directors

  • 2018

InflaRx N.V. (Nasdaq:IFRX), a bio­phar­ma­ceu­ti­cal com­pany devel­op­ing new ther­a­peu­tics in the ter­mi­nal com­ple­ment space, today announced the addi­tion of Tony Gib­ney to its Board of Direc­tors. Mr. Gib­ney is a highly expe­ri­enced life sci­ences-focused invest­ment banker and has exe­cuted over 150 financ­ings and M&A advi­sory trans­ac­tions for US and Euro­pean clients. Mr. Gibney’s appoint­ment was approved by InflaRx’ share­hold­ers at the extra­or­di­nary share­holder meet­ing held in Ams­ter­dam, the Nether­lands today.

Prof. Niels C. Riede­mann, Chief Exec­u­tive Offi­cer of InflaRx, said: «I am very excited to have Tony join our Board. Hav­ing worked with Tony dur­ing our highly suc­cess­ful IPO in 2017, I know we will greatly ben­e­fit from his finan­cial and cor­po­rate devel­op­ment exper­tise. With more than two decades of expe­ri­ence in life sci­ences invest­ment bank­ing, and with his incred­i­ble net­work in the indus­try, Tony will be a true asset to InflaRx as we grow the Company.»

Tony Gib­ney, Board mem­ber of InflaRx, said: «I am pleased to have the oppor­tu­nity to join the InflaRx‹ Board. I am impressed with the Company’s achieve­ments to date and excited about the poten­tial of InflaRx’ ther­a­peu­tic pro­grams. I look for­ward to con­tribut­ing to the Company’s con­tin­ued suc­cess as it advances its devel­op­ment programs.»

Tony Gib­ney was a life sci­ences-focused invest­ment banker for 23 years. From 2009 through 2017, he served as a man­ag­ing direc­tor and co-head of the biotech­nol­ogy invest­ment team for Leerink Part­ners LLC, where he was a senior leader of Leerink’s bio­phar­ma­ceu­ti­cal invest­ment bank­ing fran­chise. At Leerink, Mr. Gib­ney had pri­mary cov­er­age respon­si­bil­i­ties for selected East Coast bio­phar­ma­ceu­ti­cal and Euro­pean phar­ma­ceu­ti­cal clients. From 1999 to 2009, he worked as a man­ag­ing direc­tor at Mer­rill Lynch Inc. and exe­cuted a vari­ety of sig­nif­i­cant financ­ing and M&A trans­ac­tions for var­i­ous biotech­nol­ogy com­pa­nies. From 1993 to 1999, Mr. Gib­ney was an invest­ment banker at Lehman Broth­ers in the firm’s Health­care Invest­ment Bank­ing Group. He grad­u­ated with dis­tinc­tion from Yale Uni­ver­sity in 1993 with a B.A. in His­tory and Economics.

More infor­ma­tion on InflaRx’ Board is avail­able at http://www.inflarx.de/Home/About-Inflarx/Board.html

 

 

Back To Top
×Close search
Search